GNIIF (GNI Group) Short Ratio


GNIIF GNI Group Ltd GNIIF
86 GF Score
Price $15.50
GF Value $16.57
! 5 Warning Signs
View Full Analysis

What is GNI Group Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

GNIIF
86GF Score
GNI Group Ltd GNIIF
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GNI Group (GNIIF) Overvalued in 2026?

Based on GuruFocus' analysis, GNI Group stock appears to be undervalued. The current stock price of $15.50 is trading 6.5% below its estimated GF Value™ of $16.57.

Key valuation signals for GNIIF:

  • Short Ratio:
  • GF Value™: $16.57 vs. price of $15.50 (6.5% below fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the GNIIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GNI Group Business Description

Other Exchanges 2160:Japan
Address 2-2-2 Nihonbashi Honcho, 3rd Floor, Nihonbashi Honcho YS Building, Chuo-ku, Tokyo, JPN, 103-0023
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
86GF Score

Get the complete analysis for GNIIF

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.50
Price
$16.57
GF Value